ADVERTISEMENT
Search

 

Press Releases

 

18

Aug

2022

APhA Reminds Policymakers to Fix Broken PBM Marketplace to Compliment New Drug Pricing Law

(August 17, 2022) WASHINGTON, DC— The American Pharmacists Association (APhA) is pleased that the Inflation Reduction Act aims to lower health care costs for our nation’s seniors by

Comments (0)
Number of views (3778)
Article rating: No rating

25

Jul

2022

Breaking: APhA issues statement in response to Supreme Court’s Dobbs v Jackson decision

(July 25, 2022) WASHINGTON, DC— For the past month, the American Pharmacists Association (APhA) has been advocating for patients and pharmacists regarding the Dobbs v Jackson Supreme Court decision. This work has included engaging with members

Comments (0)
Number of views (7230)
Article rating: No rating

13

Jul

2022

New Federal Guidance confuses an already complicated landscape for pharmacists

Author: James Keagy

Today, in response to the U.S. Supreme Court recent decision in Dobbs v Jackson Women’s Health Organization, the U.S. Department of Health and Human Services’ Office for Civil Rights (OCR) released guidance for pharmacies that sets forth their obligations under federal civil rights laws, conflicting with some state laws, and raises concerns for our nation's pharmacies and pharmacists.

Comments (0)
Number of views (8265)
Article rating: No rating

6

Jul

2022

Breaking: FDA permits pharmacists to prescribe Paxlovid to treat COVID-19

Author: James Keagy

Today, after months of effort by APhA and other stakeholders, FDA has updated the EUA for the COVID-19 oral antiviral, Paxlovid, to permit pharmacists to order and prescribe Paxlovid under certain conditions.

Comments (0)
Number of views (14723)
Article rating: No rating

2

Jun

2022

APhA Changes Executive Leadership

Ilisa Bernstein appointed Interim CEO

The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.

Comments (0)
Number of views (17266)
Article rating: No rating
RSS
First1011121314161819
ADVERTISEMENT